Veracyte (NASDAQ:VCYT) Given New $41.00 Price Target at Needham & Company LLC
Veracyte (NASDAQ:VCYT – Get Free Report) had its target price decreased by Needham & Company LLC from $51.00 to $41.00 in a report released on Thursday,Benzinga reports. The firm currently has a “buy” rating on the biotechnology company’s stock. Needham & Company LLC’s price objective would suggest a potential upside of 39.60% from the company’s […]
Veracyte (NASDAQ:VCYT – Get Free Report) had its target price decreased by Needham & Company LLC from $51.00 to $41.00 in a report released on Thursday,Benzinga reports. The firm currently has a “buy” rating on the biotechnology company’s stock. Needham & Company LLC’s price objective would suggest a potential upside of 39.60% from the company’s […]
